Cutler Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,600
| Closed | -$279K | – | 1977 |
|
|
2023
Q4 | $279K | Buy |
+6,600
| New | +$279K | 0.03% | 334 |
|
|
2023
Q3 | – | Sell |
-270
| Closed | -$8K | – | 2122 |
|
|
2023
Q2 | $8K | Sell |
270
-930
| -78% | -$27.6K | ﹤0.01% | 1035 |
|
|
2023
Q1 | $29K | Buy |
+1,200
| New | +$29K | ﹤0.01% | 772 |
|
|
2022
Q4 | – | Sell |
-1,000
| Closed | -$28K | – | 2508 |
|
|
2022
Q3 | $28K | Sell |
1,000
-3,253
| -76% | -$91.1K | ﹤0.01% | 1090 |
|
|
2022
Q2 | $112K | Buy |
+4,253
| New | +$112K | 0.01% | 638 |
|
|
2022
Q1 | – | Sell |
-841
| Closed | -$27K | – | 2730 |
|
|
2021
Q4 | $27K | Sell |
841
-159
| -16% | -$5.11K | ﹤0.01% | 1393 |
|
|
2021
Q3 | $29K | Buy |
1,000
+957
| +2,226% | +$27.8K | ﹤0.01% | 1412 |
|
|
2021
Q2 | $1K | Buy |
+43
| New | +$1K | ﹤0.01% | 2037 |
|